Simon Farrell Insider Trades

Insider Trading History

Track insider trading activity for Simon Farrell. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Commercial Officer
Holding Value $2.78M 160,000 shares
Last Trade
Feb 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.69M 160,000 shares
$10.56
$17.38
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Commercial Officer
Holding Value $1.92M 110,400 shares
Last Trade
May 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$469k 72,000 shares
$6.51
$17.38
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Commercial Officer
Holding Value $326k 18,750 shares
Last Trade
Mar 10, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$683k 112,563 shares
$6.07
$17.38
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Commercial Officer
Holding Value $667k 38,400 shares
Last Trade
Mar 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$233k 38,400 shares
$6.07
$17.38
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Commercial Officer
Holding Value $2.75M 158,213 shares
Last Trade
Mar 10, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$683k 112,563 shares
$6.07
$17.38
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Commercial Officer
Holding Value $1.41M 81,250 shares
Last Trade
Mar 10, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$494k 81,313 shares
$6.07
$17.38
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Commercial Officer
Holding Value $3.92M 225,500 shares
Last Trade
Feb 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$952k 225,500 shares
$4.22
$17.38
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Commercial Officer
Holding Value $3.04M 175,000 shares
Last Trade
Feb 15, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$417k 175,000 shares
$2.38
$17.38
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Commercial Officer
Holding Value $793k 45,650 shares
Last Trade
Jun 20, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$16.9k 6,250 shares
$2.71
$17.38
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Commercial Officer
Holding Value $869k 50,000 shares
Last Trade
Jun 20, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$16.9k 6,250 shares
$2.71
$17.38
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Commercial Officer
Holding Value $978k 56,250 shares
Last Trade
Mar 07, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$42.2k 18,750 shares
$2.25
$17.38
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Commercial Officer
Holding Value $685k 39,400 shares
Last Trade
Mar 07, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$42.2k 18,750 shares
$2.25
$17.38
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Commercial Officer
Holding Value $1.74M 100,000 shares
Last Trade
Feb 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$267k 100,000 shares
$2.67
$17.38
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Commercial Officer
Holding Value $359k 20,650 shares
Last Trade
Feb 16, 2023 Sale
$247k 92,500 shares
$2.67
$17.38

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up